Company Filing History:
5 out of 206 
3 out of 234 
1 out of 7,680 
Years Active: 1994-2005
Title: The Innovative Contributions of David Scott Edwards
Introduction
David Scott Edwards is a prominent inventor based in Burlington, MA (US). He has made significant contributions to the field of cardiovascular disease diagnostics through his innovative patents. With a total of 12 patents to his name, Edwards has established himself as a key figure in medical research and development.
Latest Patents
Among his latest patents is the invention of labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque. These detectably labeled antagonists are useful for diagnosing and monitoring various cardiovascular diseases, including but not limited to atherosclerosis, vulnerable plaque, coronary artery disease, renal disease, thrombosis, transient ischemia due to clotting, stroke, myocardial infarction, organ transplant, organ failure, and hypercholesterolemia. This innovative approach has the potential to greatly enhance the accuracy of cardiovascular disease diagnosis and treatment.
Career Highlights
Throughout his career, David Scott Edwards has worked with notable companies such as the DuPont Merck Pharmaceutical Company and Bristol-Myers Squibb Pharma Company. His experience in these leading pharmaceutical firms has allowed him to develop groundbreaking technologies that address critical health issues.
Collaborations
Edwards has collaborated with talented individuals in the field, including Shuang Liu and Milind Rajopadhye. These partnerships have fostered an environment of innovation and have contributed to the advancement of medical research.
Conclusion
David Scott Edwards is a distinguished inventor whose work has significantly impacted the field of cardiovascular diagnostics. His innovative patents and collaborations continue to pave the way for advancements in medical technology.